VivoSeq
Other

Olanzapine

0

Pipeline Programs↗

1

Active Trials↗

7

Companies Involved↗

Olanzapine is an early-stage landscape with 0 programs across 7 companies. The most active players are Eli Lilly, Mylan Pharmaceuticals Inc, Torrent Pharmaceuticals Limited.

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

87/100

Attrition Rate

12/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Eli Lilly logo

Eli Lilly

0 programs

PreclinicalMylan Pharmaceuticals Inc logo

Mylan Pharmaceuticals Inc

0 programs

PreclinicalT

Torrent Pharmaceuticals Limited

0 programs

PreclinicalR

Response Pharmaceuticals

0 programs

PreclinicalJohnson & Johnson logo

Johnson & Johnson

0 programs

PreclinicalP

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

49

clinical trials

Completed39 · 80%
Terminated5 · 10%
Unknown status3 · 6%
Recruiting1 · 2%
Withdrawn1 · 2%

Clinical Trials

Trial Activity

49 trials

Comparing Haloperidol to Olanzapine in the Treatment of Suspected Cannabinoid Hyperemesis in the Emergency Department
Recruiting·—·Phase 3·NCT07246187·114 enrolled
Effect of RDX-002 on Postprandial Triglycerides in Subjects Treated With Olanzapine
Completed·RResponse Pharmaceuticals·Phase 1·NCT05857566·24 enrolled
Fasted Bioequivalence Study of 2 Olanzapine Film-coated Tablets, 5 mg, in Healthy, Adult Male and Female Subjects.
Completed·JJoint Stock Company "Farmak"·Phase 1·NCT05123976·32 enrolled
Patient's Preference Between Conventional Oral Olanzapine Tablet vs Olanzapine Orodispersible Tablet
Completed·Eli Lilly logoEli Lilly·Phase 4·NCT00324051·284 enrolled
Evaluation of Co-Administration of Betahistine as Adjunctive to Olanzapine in Healthy Subjects
Completed·OOBEcure Ltd.·Phase 1·NCT01168336·90 enrolled
Comparison of Combination Olanzapine+Lithium or Chlorpromazine+Lithium in Treatment of First Manic Episode With Psychotic Features
Completed·MMelbourne Health·Phase 4·NCT00202293·83 enrolled
Olanzapine vs. Low-dose Olanzapine Plus Trifluoperazine
Completed·KKaohsiung Kai-Suan Psychiatric Hospital·Phase 4·NCT02704962·94 enrolled
Assessment and Comparison of Metabolic Changes in Non-psychotic Adults Taking Iloperidone or Olanzapine or Placebo
Completed·NNew York State Psychiatric Institute·Phase 4·NCT01920802·31 enrolled
Short Term Rescue Study of Olanzapine
Completed·SStanford University·Phase 4·NCT00186017·50 enrolled
Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Olanzapine Orally Disintegrating 5mg Tablets Under Fasting Condition
Completed·TTorrent Pharmaceuticals Limited·Phase 1·NCT01996488
Fasting Study of Olanzapine Tablets 5 mg and Zyprexa® Tablets 5 mg
Completed·Mylan Pharmaceuticals Inc logoMylan Pharmaceuticals Inc·Phase 1·NCT00648921·30 enrolled
A Study of Treatment Success in Changing From Olanzapine to Long-acting Injectable Risperidone (RISPERDAL® CONSTA™)
Completed·Johnson & Johnson logoJohnson & Johnson·Phase 4·NCT00216632·99 enrolled
3-Week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07008)
Completed·—·Phase 3·NCT00159744·488 enrolled
A Crossover Study of the Acute Effects of Olanzapine in Healthy Volunteers
Completed·MMilton S. Hershey Medical Center·N/A·NCT00741026·15 enrolled
The Effects of Risperidone and Olanzapine on Thinking
Completed·US Department of Veterans Affairs·Phase 4·NCT00108368
Page 1 of 4

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)